Prepare for Health Catalyst (HCAT) Q4 Results: Analyst Projections for Major Performance Indicators

Health Catalyst Q4 Earnings Preview: Analyst Expectations

According to Wall Street forecasts, Health Catalyst (HCAT) is anticipated to report quarterly earnings of $0.10 per share in its upcoming release, marking a 150% increase compared to the same quarter last year. However, revenue is projected to reach $73.61 million, which would be a 7.5% decline year-over-year.

Over the last month, analysts have maintained their consensus estimate for HCAT's earnings per share, indicating a period of reassessment but no significant changes in outlook.

The Importance of Earnings Estimate Revisions

As companies approach their earnings announcements, shifts in analyst estimates can be a key indicator of how investors might react. Numerous studies have shown that changes in earnings projections often correlate with short-term stock price movements.

While consensus estimates for earnings and revenue provide a snapshot of expected performance, a closer look at forecasts for specific business segments can offer deeper insights into a company's health.

Key Metrics to Watch for Health Catalyst

• Professional Services Revenue: Analysts expect this segment to generate $22.88 million, reflecting an 18.3% decrease from the prior year.
• Technology Revenue: The consensus estimate is $50.74 million, a slight 1.7% drop year-over-year.
• Adjusted Gross Profit – Professional Services: Forecasts suggest $4.22 million, up from $3.78 million in the same quarter last year.
• Adjusted Gross Profit – Technology: Analysts predict $34.30 million, compared to $33.35 million a year ago.

Recent Stock Performance and Analyst Ratings

In the past month, Health Catalyst shares have declined by 9.3%, while the Zacks S&P 500 composite index fell 2.7% over the same period. Currently, HCAT holds a Zacks Rank #2 (Buy), indicating expectations that the stock may outperform the broader market in the near term.

5 Stocks with Potential to Double

Zacks experts have identified five stocks they believe could rise by 100% or more in the next year. While not every pick is a guaranteed winner, past selections have delivered gains of 112%, 171%, 209%, and even 232%.

Many of these stocks are not widely followed by Wall Street, offering investors a unique opportunity to invest early.

Get More Stock Recommendations

Looking for more investment ideas? Download Zacks Investment Research’s list of the 7 Best Stocks for the Next 30 Days.